China's PLA delivers a batch of coronavirus vaccines to Pakistan Army

Chinese military delivered a batch of COVID-19 vaccines to the Pakistan Army on Sunday, days after Islamabad received 500,000 doses of the coronavirus vaccine from its all-weather ally Beijing.

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Press Trust of India Beijing
2 min read Last Updated : Feb 07 2021 | 6:00 PM IST

Chinese military delivered a batch of COVID-19 vaccines to the Pakistan Army on Sunday, days after Islamabad received 500,000 doses of the coronavirus vaccine from its all-weather ally Beijing.

The People's Liberation Army (PLA) said in a statement that the Pakistan Army has become the first foreign military to receive the COVID-19 vaccine aid from the Chinese military.

The statement, however, did not mention the number of vaccines supplied to the Pakistan Army.

The PLA also delivered a batch of COVID-19 vaccines to the Cambodian military after receiving a request for it.

The Cambodian Army was among the first batch of the foreign military to receive COVID-19 vaccine aid from the Chinese military, the state-run Xinhua news agency reported.

The vaccines delivered to the Pakistan Army are reportedly in addition to the five lakh doses provided by China to Pakistan. Pakistan on Monday received the first batch of 500,000 doses of the coronavirus vaccine from China, as the country was gearing up to kick start its immunisation drive.

The move comes as the number of COVID-19 cases in Pakistan reached 554,474. With 53 new deaths, the number of fatalities has gone up to 11,967, according to the Ministry of National Health Services.

China has granted conditional approval for its second COVID-19 vaccine, ahead of the expected emergency approval from the WHO for two of its jabs that would enable the country to step-up global supplies of the shots.

Sinovac Biotech announced on Saturday that CoronaVac, an inactivated vaccine candidate against COVID-19, received authorisation from the National Medical Products Administration for conditional mass use in China.

It is the second locally made vaccine to be given conditional approval. Beijing authorised the state-owned Sinopharm's vaccine in December.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus

First Published: Feb 07 2021 | 5:54 PM IST

Next Story